4/A: Amicus Therapeutics Executive Jeff Castelli Corrects Previous SEC Filing Regarding Stock Transactions
SEC Filing Amendment
Jeff Castelli, Chief Development Officer at Amicus Therapeutics, amends a previous SEC filing to accurately reflect stock acquisitions and holdings following the vesting of performance-based restricted stock units (PRSUs) and subsequent tax withholdings.
Summary
- Jeff Castelli, Chief Development Officer of Amicus Therapeutics, filed an amended Form 4 with the SEC.
- The amendment corrects a previous filing from January 11, 2024, which incorrectly excluded the acquisition of shares related to the 2021 PRSU TSR goal and reported incorrect holdings after tax withholdings.
- On January 9, 2024, Castelli acquired 14,405 shares of common stock at $0.00 related to the achievement of the 2021 PRSU TSR goal.
- Also on January 9, 2024, 10,005 shares were disposed of at $13.65 per share to cover taxes.
- Following these transactions, Castelli directly owns 377,205 shares of Amicus Therapeutics common stock.
Sentiment
Score: 7
Explanation: The sentiment is neutral as it is a correction of a previous filing. The correction itself doesn't indicate positive or negative performance, but rather ensures accurate reporting.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common in the pharmaceutical industry.
Stakeholder Impact
- Shareholders benefit from accurate reporting of executive stock ownership.
- The company maintains compliance with SEC regulations.
Key Dates
| Date | Description |
|---|---|
| 01/09/2024 | Date of stock acquisition and disposal for tax purposes. |
| 01/11/2024 | Date of original Form 4 filing containing errors. |
| 03/15/2024 | Date of amended Form 4/A filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.